The Minds Behind
Synthetica
Behind Synthetica is a diverse team of scientists, innovators, and industry leaders united by a passion for breakthrough biotechnology. Our leadership and advisors combine deep expertise in biotech research, synthetic biology, dermatology, regulatory affairs, and entrepreneurship. Together, we have the experience to execute on our vision and the dedication to make a global impact.
Founding Team
Co-Founder & Chief Executive Officer
Dabier Ebrahem Miya
A serial entrepreneur and venture-builder, Dabier leads Synthetica’s strategy and operations. With a proven track record in launching and scaling startups, he blends agile execution with visionary leadership to commercialize algae-based technologies and build strategic partnerships that power growth.
PhD – Co-Founder & Chief Scientific Officer
Professor Saul Purton
A world-renowned algal biotechnologist with 30+ years at UCL, Prof. Purton is a pioneer in algal genetic engineering and has authored over 150 scientific papers. As President of the British Phycological Society and Director of Algae-UK, he brings unmatched scientific leadership to Synthetica, driving innovation and ensuring our technology remains cutting-edge.
Co-Founder & Chief Operating Officer
Tea Sankovic
An expert in go-to-market strategy and revenue growth, Tea drives execution across operations and customer acquisition. Her experience scaling startups ensures Synthetica’s innovations are commercially viable, market-ready, and aligned with business goals.
Advisory Board
Founder & Chairman, Algenuity
Dr. Andrew Spicer
Founder of leading algae tech firm Algenuity, Dr. Spicer brings deep insight into scaling algal innovations from lab to market. His experience helps shape Synthetica’s R&D and growth strategy for real-world impact.
Investment Associate, 2150 VC
Dr. Max Blanshard
A molecular biologist-turned-investor, Max bridges science and business. His experience in medtech and VC provides critical guidance on fundraising, commercial strategy, and market positioning.
Head of Regulatory & Clinical Affairs, Dermal Laboratories
Sush Gianfrancesco
With nearly two decades in regulatory affairs, Sush ensures Synthetica’s therapies meet rigorous quality and compliance standards. Her expertise is key as we prepare products like CutiBac™ for clinical validation
Dermatology Consultant
Dr. Karishma Hemmady
A respected dermatologist and clinical trials expert, Dr. Hemmady offers essential medical insight for Synthetica’s skin health products. Her guidance ensures our therapies are both clinically effective and patient-focused.